carmustine has been researched along with acridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarcon, K; Carrez, D; Croisy, A; Demeunynck, M; Lhomme, J | 1 |
| Anderson, JG; Bierbach, U; Hess, SM | 1 |
2 other study(ies) available for carmustine and acridines
| Article | Year |
|---|---|
Diaminopurine-acridine heterodimers for specific recognition of abasic site containing DNA. Influence on the biological activity of the position of the linker on the purine ring.
Topics: 2-Aminopurine; Acridines; Animals; Base Sequence; Carmustine; Cell Line; Dimerization; DNA Damage; Inhibitory Concentration 50; Intercalating Agents; Nucleic Acid Denaturation; Oligonucleotides; Purines; Thermodynamics | 2001 |
A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
Topics: Acridines; Animals; Carmustine; Caspase 3; Caspases; Cell Line; Cisplatin; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Inhibitory Concentration 50; Organoplatinum Compounds; Platinum | 2005 |